About Jasper Therapeutics, Inc. Common Stock
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
Market Cap
$0.07B
Employees
64
Listed Since
September 27, 2021
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Website
www.jaspertherapeutics.comPhone
(650) 549-1400
Headquarters
2200 BRIDGE PKWY SUITE #102
REDWOOD CITY, CA 94065
CIK
0001788028